Annual Operating Profit:
-$145.85M-$70.79M(-94.30%)Summary
- As of today, EYPT annual operating income is -$145.85 million, with the most recent change of -$70.79 million (-94.30%) on December 31, 2024.
- During the last 3 years, EYPT annual operating profit has fallen by -$90.58 million (-163.86%).
- EYPT annual operating profit is now -1704.38% below its all-time high of $9.09 million, reached on June 30, 2010.
Performance
EYPT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$62.23M-$13.39M(-27.42%)Summary
- As of today, EYPT quarterly operating income is -$62.23 million, with the most recent change of -$13.39 million (-27.42%) on June 30, 2025.
- Over the past year, EYPT quarterly operating profit has dropped by -$27.68 million (-80.13%).
- EYPT quarterly operating profit is now -399.33% below its all-time high of $20.79 million, reached on September 30, 2014.
Performance
EYPT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$189.05M-$27.68M(-17.15%)Summary
- As of today, EYPT TTM operating income is -$189.05 million, with the most recent change of -$27.68 million (-17.15%) on June 30, 2025.
- Over the past year, EYPT TTM operating profit has dropped by -$90.43 million (-91.70%).
- EYPT TTM operating profit is now -1828.23% below its all-time high of $10.94 million, reached on September 30, 2014.
Performance
EYPT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EYPT Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -94.3% | -80.1% | -91.7% |
| 3Y3 Years | -163.9% | -223.8% | -166.8% |
| 5Y5 Years | -204.7% | -458.0% | -463.7% |
EYPT Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -163.9% | at low | -332.2% | at low | -155.7% | at low |
| 5Y | 5-Year | -291.1% | at low | -3079.7% | at low | -463.7% | at low |
| All-Time | All-Time | -1704.4% | at low | -399.3% | at low | -1828.2% | at low |
EYPT Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$62.23M(-27.4%) | -$189.05M(-17.2%) |
| Mar 2025 | - | -$48.84M(-8.0%) | -$161.37M(-10.6%) |
| Dec 2024 | -$145.85M(-94.3%) | -$45.24M(-38.1%) | -$145.85M(-24.7%) |
| Sep 2024 | - | -$32.75M(+5.2%) | -$116.97M(-18.6%) |
| Jun 2024 | - | -$34.55M(-3.7%) | -$98.62M(-13.6%) |
| Mar 2024 | - | -$33.32M(-103.7%) | -$86.83M(-15.7%) |
| Dec 2023 | -$75.07M(+4.9%) | -$16.35M(-13.6%) | -$75.07M(+8.2%) |
| Sep 2023 | - | -$14.40M(+36.7%) | -$81.75M(+4.7%) |
| Jun 2023 | - | -$22.76M(-5.6%) | -$85.75M(-4.3%) |
| Mar 2023 | - | -$21.55M(+6.4%) | -$82.20M(-4.1%) |
| Dec 2022 | -$78.94M(-42.8%) | -$23.04M(-25.2%) | -$78.93M(-6.7%) |
| Sep 2022 | - | -$18.40M(+4.3%) | -$73.95M(-4.4%) |
| Jun 2022 | - | -$19.22M(-5.1%) | -$70.86M(-13.2%) |
| Mar 2022 | - | -$18.28M(-1.3%) | -$62.63M(-13.3%) |
| Dec 2021 | -$55.28M(-48.2%) | -$18.05M(-17.9%) | -$55.28M(-10.6%) |
| Sep 2021 | - | -$15.31M(-39.5%) | -$49.96M(-36.5%) |
| Jun 2021 | - | -$10.98M(-0.4%) | -$36.61M(+0.5%) |
| Mar 2021 | - | -$10.94M(+14.1%) | -$36.78M(+1.4%) |
| Dec 2020 | -$37.29M(+22.1%) | -$12.74M(-550.8%) | -$37.29M(-11.2%) |
| Sep 2020 | - | -$1.96M(+82.5%) | -$33.54M(+26.5%) |
| Jun 2020 | - | -$11.15M(+2.6%) | -$45.64M(-2.2%) |
| Mar 2020 | - | -$11.44M(-27.4%) | -$44.66M(+6.7%) |
| Dec 2019 | -$47.86M(-94.9%) | -$8.99M(+36.1%) | -$47.86M(-88.2%) |
| Sep 2019 | - | -$14.06M(-38.3%) | -$25.43M(-2.0%) |
| Jun 2019 | - | -$10.16M(+30.6%) | -$24.92M(-1.6%) |
| Mar 2019 | - | -$14.65M(-209.0%) | -$24.54M(-68.5%) |
| Dec 2018 | - | $13.45M(+199.2%) | -$14.57M(+48.0%) |
| Dec 2018 | -$24.56M(-32.2%) | - | - |
| Sep 2018 | - | -$13.55M(-38.6%) | -$28.01M(-93.7%) |
| Jun 2018 | - | -$9.78M(-109.1%) | -$14.46M(-33.7%) |
| Mar 2018 | - | -$4.68M(+23.8%) | -$10.81M(+40.3%) |
| Jun 2017 | -$18.58M(+14.7%) | -$6.14M(-18.9%) | -$18.10M(+1.7%) |
| Mar 2017 | - | -$5.16M(-8796.6%) | -$18.42M(-0.1%) |
| Dec 2016 | - | -$58.00K(+99.1%) | -$18.40M(+22.1%) |
| Sep 2016 | - | -$6.75M(-4.6%) | -$23.62M(-7.9%) |
| Jun 2016 | -$21.77M(-439.1%) | -$6.46M(-25.7%) | -$21.89M(-6.1%) |
| Mar 2016 | - | -$5.13M(+2.7%) | -$20.64M(-0.4%) |
| Dec 2015 | - | -$5.28M(-4.9%) | -$20.56M(-6.0%) |
| Sep 2015 | - | -$5.03M(+3.3%) | -$19.40M(-402.1%) |
| Jun 2015 | $6.42M(+147.3%) | -$5.20M(-2.9%) | $6.42M(-15.6%) |
| Mar 2015 | - | -$5.05M(-22.7%) | $7.61M(-27.1%) |
| Dec 2014 | - | -$4.12M(-119.8%) | $10.44M(-4.6%) |
| Sep 2014 | - | $20.79M(+617.9%) | $10.94M(+180.6%) |
| Jun 2014 | -$13.57M | -$4.01M(-80.6%) | -$13.57M(-0.2%) |
| Mar 2014 | - | -$2.22M(+38.5%) | -$13.54M(+4.2%) |
| Dec 2013 | - | -$3.61M(+2.8%) | -$14.12M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$3.72M(+6.6%) | -$13.16M(-9.4%) |
| Jun 2013 | -$12.03M(-15.9%) | -$3.98M(-41.6%) | -$12.03M(-16.1%) |
| Mar 2013 | - | -$2.81M(-6.2%) | -$10.36M(-0.8%) |
| Dec 2012 | - | -$2.65M(-2.2%) | -$10.28M(+1.6%) |
| Sep 2012 | - | -$2.59M(-12.1%) | -$10.44M(-0.6%) |
| Jun 2012 | -$10.38M(-3.8%) | -$2.31M(+15.3%) | -$10.38M(-23.9%) |
| Mar 2012 | - | -$2.73M(+3.1%) | -$8.38M(+4.7%) |
| Dec 2011 | - | -$2.81M(-11.1%) | -$8.79M(+3.4%) |
| Sep 2011 | - | -$2.53M(-721.8%) | -$9.10M(+9.0%) |
| Jun 2011 | -$10.00M(-210.0%) | -$308.00K(+90.2%) | -$10.00M(-503.5%) |
| Mar 2011 | - | -$3.14M(-0.6%) | $2.48M(-10.0%) |
| Dec 2010 | - | -$3.12M(+9.1%) | $2.75M(-52.2%) |
| Sep 2010 | - | -$3.44M(-128.2%) | $5.76M(-36.6%) |
| Jun 2010 | $9.09M(+296.1%) | $12.17M(+525.2%) | $9.09M(+389.7%) |
| Mar 2010 | - | -$2.86M(-2433.6%) | -$3.14M(-197.2%) |
| Dec 2009 | - | -$113.00K(-5.6%) | -$1.06M(+55.3%) |
| Sep 2009 | - | -$107.00K(-94.5%) | -$2.36M(+49.0%) |
| Jun 2009 | -$4.64M(+81.4%) | -$55.00K(+93.0%) | -$4.64M(+51.8%) |
| Mar 2009 | - | -$781.00K(+45.0%) | -$9.62M(+37.7%) |
| Dec 2008 | - | -$1.42M(+40.3%) | -$15.45M(+30.0%) |
| Sep 2008 | - | -$2.38M(+52.8%) | -$22.07M(+11.4%) |
| Jun 2008 | -$24.90M(+29.9%) | -$5.04M(+23.7%) | -$24.90M(+56.5%) |
| Mar 2008 | - | -$6.61M(+17.8%) | -$57.18M(-13.2%) |
| Dec 2007 | - | -$8.04M(-54.2%) | -$50.51M(+0.9%) |
| Sep 2007 | - | -$5.21M(+86.0%) | -$50.97M(-13.4%) |
| Jun 2007 | -$35.54M(-28.4%) | -$37.32M(>-9900.0%) | -$44.97M(-23.6%) |
| Mar 2007 | - | $65.00K(+100.8%) | -$36.38M(-0.8%) |
| Dec 2006 | - | -$8.50M(-1175.4%) | -$36.09M(-34.1%) |
| Sep 2006 | - | $790.40K(+102.8%) | -$26.92M(+1.5%) |
| Jun 2006 | -$27.68M(-90.2%) | -$28.73M(-8264.7%) | -$27.33M(-100.5%) |
| Mar 2006 | - | $351.90K(-47.5%) | -$13.63M(+1.4%) |
| Dec 2005 | - | $670.70K(+78.8%) | -$13.82M(+3.6%) |
| Sep 2005 | - | $375.10K(+102.5%) | -$14.33M(+1.5%) |
| Jun 2005 | -$14.55M(-133.3%) | -$15.03M(-9470.5%) | -$14.56M(-143.3%) |
| Mar 2005 | - | $160.40K(-0.9%) | -$5.98M(+1.4%) |
| Dec 2004 | - | $161.80K(+7.4%) | -$6.07M(+1.5%) |
| Sep 2004 | - | $150.70K(+102.3%) | -$6.16M(+1.4%) |
| Jun 2004 | -$6.24M(-73.4%) | -$6.46M(-8954.7%) | -$6.25M(-81.7%) |
| Mar 2004 | - | $72.90K(+1.5%) | -$3.44M(+1.6%) |
| Dec 2003 | - | $71.80K(+10.6%) | -$3.49M(+1.6%) |
| Sep 2003 | - | $64.90K(+101.8%) | -$3.55M(+1.4%) |
| Jun 2003 | -$3.60M(-181.3%) | -$3.65M(>-9900.0%) | -$3.60M(-7728.4%) |
| Mar 2003 | - | $16.70K(+7.7%) | $47.20K(+54.8%) |
| Dec 2002 | - | $15.50K(+3.3%) | $30.50K(+103.3%) |
| Sep 2002 | - | $15.00K | $15.00K |
| Jun 2002 | -$1.28M(-194.2%) | - | - |
| Jun 2001 | -$434.60K | - | - |
FAQ
- What is EyePoint Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is EyePoint Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of EYPT is -$145.85M
What is the all-time high annual operating profit for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high annual operating income is $9.09M
What is EyePoint Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, EYPT annual operating income has changed by -$70.79M (-94.30%)
What is EyePoint Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of EYPT is -$62.23M
What is the all-time high quarterly operating profit for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high quarterly operating income is $20.79M
What is EyePoint Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, EYPT quarterly operating income has changed by -$27.68M (-80.13%)
What is EyePoint Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of EYPT is -$189.05M
What is the all-time high TTM operating profit for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high TTM operating income is $10.94M
What is EyePoint Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, EYPT TTM operating income has changed by -$90.43M (-91.70%)